Skip to Main Content

Paper Details

Genome Analysis of Osteosarcoma Progression Samples Identifies FGFR1 Overexpression as a Potential Treatment Target and CHM as a Candidate Tumor Suppressor Gene.
PLoS One
11
2016
Author NameAffiliation
Ola MyklebostInstitute for Cancer Research, Norwegian Radium Hospital, Oslo University Hospital
Ola Myklebost
  • 1 - 2

Datasets

Release 1.2